Valeant Pharmaceuticals International Inc said it increased its offer for Salix Pharmaceuticals Inc to $10.96 billion in cash, topping Endo International Plc's bid of $10.93 billion in cash and stock for the bowel drug maker.
Breaking News
- Florida Man Sets Himself on Fire in Broad Daylight Outside Donald Trump Hush Money Trial Courthouse
- Joe Biden Bashes Donald Trump for Inheriting His Wealth as He Touts His Middle-Class Upbringing in Union Speech
- ASML's Potential Exit from the Netherlands: Dutch Minister Remains Optimistic About Company's Future
Valeant Pharmaceuticals International Inc (VRX.TO) plans to raise its bid for Salix Pharmaceuticals Ltd (SLXP.O) close to $170 per share, a person familiar with matter told Reuters.
Canada's Valeant Pharmaceuticals International Inc.
Prominent investor shareholder advisory firm ISS called on Allergan Inc to give its shareholders a chance to vote on any large, buyout-blocking acquisitions and said the company's board faced a credibility problem, according to a report seen by Reuters.
Subscribe to VCpost newsletter
Most Popular
- American Millionaire Charged in Brutal Murders of Canadian Tycoon and His Partner in Dominica Denied Bail
- SSDI Payment April 2024: Who Will Receive Social Security Benefits Today?
- Where's My Child Tax Credit 2024: When to Receive My Money After April 15 Tax Filing Deadline?
- Tesla Spends $200,000 in Promoting Elon Musk's Social Media Platform X Following Mention of 'Minimal Advertising Efforts'
- Michigan Family Sues Wendy's for $20 Million After 11-Year-Old Girl Suffered Deadly E.Coli Infection
- Brazilian Woman Wheels Her Dead Uncle Into the Bank to Withdraw Loan in His Name
- Social Security Benefits: 2025 COLA Predicted to Increase Amid Rising Inflation
- Sheetz Convenience Store Accused of Racial Discrimination After Denying Employment of Black, Mixed-Race, and Native American Applicants
